Healthcare
AMGN
Amgen Inc.
$347.94-1.51%
Conviction Score
64/100
Data aggregation, not advice
About Amgen Inc.
Amgen is a biotechnology company that makes drugs for serious diseases including cancer, heart disease, and bone conditions. Their products include Enbrel, Repatha, and biosimilars. The company generates strong cash flow and returns money to shareholders through dividends and buybacks.
Full research is for ConvictionStocks members
Unlock Full AccessScore Breakdown
How each category contributes to the overall Conviction Score.
Full research is for ConvictionStocks members
Unlock Full AccessWhat Analysts Think
Full research is for ConvictionStocks members
Unlock Full AccessRecent News
Full research is for ConvictionStocks members
Unlock Full AccessRelated Research
More Healthcare stocks to explore